Department of Health and Human Services Overhauls Federal Healthcare Procurement and Pharmaceutical Pricing Transparency Rules
The United States Department of Health and Human Services announced major regulatory updates designed to increase price transparency for prescription drugs, reduce administrative burdens on healthcare providers, and reform Medicare reimbursement structures.